DE69016755D1 - Pharmazeutische Zubereitung mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen. - Google Patents

Pharmazeutische Zubereitung mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen.

Info

Publication number
DE69016755D1
DE69016755D1 DE69016755T DE69016755T DE69016755D1 DE 69016755 D1 DE69016755 D1 DE 69016755D1 DE 69016755 T DE69016755 T DE 69016755T DE 69016755 T DE69016755 T DE 69016755T DE 69016755 D1 DE69016755 D1 DE 69016755D1
Authority
DE
Germany
Prior art keywords
delayed
treatment
pharmaceutical preparation
release pharmaceutical
periodontal diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69016755T
Other languages
English (en)
Other versions
DE69016755T2 (de
Inventor
Nalinkant Chunilal Damani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27031904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69016755(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of DE69016755D1 publication Critical patent/DE69016755D1/de
Application granted granted Critical
Publication of DE69016755T2 publication Critical patent/DE69016755T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DE69016755T 1989-11-17 1990-11-08 Pharmazeutische Zubereitung mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen. Expired - Fee Related DE69016755T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43906689A 1989-11-17 1989-11-17
US07/573,604 US5198220A (en) 1989-11-17 1990-08-24 Sustained release compositions for treating periodontal disease

Publications (2)

Publication Number Publication Date
DE69016755D1 true DE69016755D1 (de) 1995-03-23
DE69016755T2 DE69016755T2 (de) 1995-09-21

Family

ID=27031904

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69016755T Expired - Fee Related DE69016755T2 (de) 1989-11-17 1990-11-08 Pharmazeutische Zubereitung mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen.

Country Status (14)

Country Link
US (1) US5198220A (de)
EP (1) EP0430474B1 (de)
JP (1) JP3051154B2 (de)
KR (1) KR0156917B1 (de)
AT (1) ATE118170T1 (de)
AU (1) AU648278B2 (de)
CA (1) CA2029046C (de)
DE (1) DE69016755T2 (de)
DK (1) DK0430474T3 (de)
ES (1) ES2067696T3 (de)
FI (1) FI98126C (de)
GR (1) GR3015027T3 (de)
IE (1) IE66371B1 (de)
NZ (1) NZ236113A (de)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309669B1 (en) * 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
FR2691360B1 (fr) * 1992-05-20 1995-06-30 3P Agence Conseil Compositions pharmaceutiques destinees en particulier au traitement des poches parondontales et procede de fabrication.
NZ247712A (en) * 1992-06-19 1995-04-27 Colgate Palmolive Co Oral composition comprising an anti-bacterial compound, a water-insoluble biodegradable polymer, and an organic solvent
US5922340A (en) * 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5242910A (en) * 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US6015844A (en) * 1993-03-22 2000-01-18 Johnson & Johnson Medical, Inc. Composite surgical material
US6001895A (en) * 1993-03-22 1999-12-14 Johnson & Johnson Medical, Inc. Composite surgical material
GB2280850B (en) * 1993-07-28 1997-07-30 Johnson & Johnson Medical Absorbable composite materials for use in the treatment of periodontal disease
US5447725A (en) * 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
EP0721324A1 (de) * 1993-10-01 1996-07-17 The Procter & Gamble Company Verwendung von azithromycin zur behandlung von paradontose bei erwachsenen und topische zubereitungen für die verwendung
US5639466A (en) * 1994-02-24 1997-06-17 Chronopol, Inc. Method for packaging foodstuffs
UA41995C2 (uk) 1994-05-06 2001-10-15 Пфайзер Інк. Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти )
JPH08113534A (ja) * 1994-10-17 1996-05-07 Ichiro Umeuchi 歯周病治療器具
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US6413539B1 (en) 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US6551610B2 (en) 1995-04-13 2003-04-22 Poly-Med, Inc. Multifaceted compositions for post-surgical adhesion prevention
US5942241A (en) 1995-06-09 1999-08-24 Euro-Celtique, S.A. Formulations and methods for providing prolonged local anesthesia
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
JPH11511763A (ja) 1996-06-24 1999-10-12 ユーロ―セルティーク，エス．エイ． 安全な局所麻酔の提供方法
US6046187A (en) * 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
JP4268227B2 (ja) * 1997-03-18 2009-05-27 サンスター株式会社 固体粒子形成用組成物
US5962006A (en) * 1997-06-17 1999-10-05 Atrix Laboratories, Inc. Polymer formulation for prevention of surgical adhesions
BR9815499A (pt) * 1997-07-02 2001-01-02 Euro Celtique Sa Anestesia prolongada nas juntas e nos espacos corporais.
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
US6245345B1 (en) 1998-07-07 2001-06-12 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
US6152943A (en) 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
DE69943297D1 (de) * 1998-08-14 2011-05-05 Incept Llc Apparat für die in-situ-bildung von hydrogelen
US6605294B2 (en) * 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6179862B1 (en) 1998-08-14 2001-01-30 Incept Llc Methods and apparatus for in situ formation of hydrogels
US6514534B1 (en) * 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6626870B1 (en) 2000-03-27 2003-09-30 Artix Laboratories, Inc. Stoppering method to maintain sterility
US6566144B1 (en) 2000-03-27 2003-05-20 Atrix Laboratories Cover plate for use in lyophilization
PE20020237A1 (es) * 2000-06-30 2002-04-18 Procter & Gamble Composicion oral topica
PE20020102A1 (es) 2000-06-30 2002-03-06 Procter & Gamble Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales
US8283135B2 (en) 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
US8470359B2 (en) 2000-11-13 2013-06-25 Qlt Usa, Inc. Sustained release polymer
WO2002058670A1 (en) * 2001-01-25 2002-08-01 Euroceltique S.A. Local anesthetic, and method of use
JP2003231622A (ja) * 2001-12-04 2003-08-19 Kao Corp 口腔用組成物
NZ574520A (en) 2002-11-27 2011-02-25 Dmi Biosciences Inc Use of casein which is at least 10% dephosphorylated for the treatment of diseases and conditions mediated by increased phosphorylation
CN1886126A (zh) * 2003-09-25 2006-12-27 Dmi生物科学公司 利用n－酰基－l－天冬氨酸的方法和产品
US20050084551A1 (en) 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
US20050125033A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Wound closure apparatus
US20050125015A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Tissue-handling apparatus, system and method
AU2005272925B2 (en) * 2004-08-13 2011-02-10 Intervet International B.V. Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid
US8916050B2 (en) * 2004-09-27 2014-12-23 Special Water Patents B.V. Methods and compositions for treatment of water
US7611494B2 (en) 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
US20090104242A1 (en) * 2005-07-28 2009-04-23 Indiana University Research & Technology Corporati Niobium oxide compositions, nanostructures, bioactive forms and uses thereof
EP1948236B1 (de) 2005-09-27 2021-03-03 Special Water Patents B.V. Methoden und zusammensetzungen zur behandlung der haut
US20070178220A1 (en) * 2006-01-31 2007-08-02 Karlinsey Robert L Materials and methods for manufacturing amorphous tricalcium phosphate and metal oxide alloys of amorphous tricalcium phosphate and methods of using the same
CA2669514C (en) 2006-11-13 2015-11-03 The Procter & Gamble Company Products and methods for disclosing conditions in the oral cavity
US8298516B2 (en) * 2006-12-22 2012-10-30 Douglas Anderson Calculus dissolving dental composition and methods for using same
US20090088723A1 (en) * 2007-09-28 2009-04-02 Accessclosure, Inc. Apparatus and methods for treating pseudoaneurysms
WO2009134783A1 (en) * 2008-05-02 2009-11-05 The Procter & Gamble Company Products and methods for disclosing conditions in the oral cavity
ES2560202T3 (es) 2008-11-25 2016-02-17 The Procter & Gamble Company Composiciones para el cuidado bucal con sílice fundida
JP5890182B2 (ja) 2009-02-12 2016-03-22 インセプト エルエルシー ヒドロゲルプラグによる薬物送達
EP2448406B1 (de) 2009-02-26 2016-04-20 Relmada Therapeutics, Inc. Oral einnehmbare pharmazeutische zusammensetzungen aus 3-hydroxy-n-methylmorphinan mit verzögerter freisetzung und verwendungsverfahren dafür
EP2413883A1 (de) 2009-04-01 2012-02-08 Colgate-Palmolive Company Zahnputzzusammensetzungen und verfahren zur behandlung und prophylaxe von beschädigungen der zahnoberfläche
US8434489B2 (en) 2009-10-23 2013-05-07 Conceptus, Inc. Contraceptive devices and methods
US20110104081A1 (en) 2009-11-03 2011-05-05 Douglas Craig Scott Oral Compositions for Treatment of Dry Mouth
US20110104080A1 (en) 2009-11-03 2011-05-05 David Salloum Salloum Oral Compositions for Treatment of Dry Mouth
BR112012025099A2 (pt) 2010-04-01 2016-06-21 Procter & Gamble Comapny controle total de odor bucal desagradável por meio de uma combinação de agentes bactericidas e de desodorização
MX2013000640A (es) 2010-07-19 2013-03-22 Procter & Gamble Composiciones que comprenden derivados de compuestos de aceites esenciales y uso en productos para el cuidado personal.
US20120076734A1 (en) * 2010-09-15 2012-03-29 Jacob Olson Radiopaque antibiotic dental paste and uses thereof
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
CA2858161C (en) 2011-12-05 2020-03-10 Incept, Llc Medical organogel processes and compositions
US20130344120A1 (en) 2012-06-21 2013-12-26 Douglas Craig Scott Mouth Rinse Emulsions
US10123953B2 (en) 2012-06-21 2018-11-13 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
IN2015DN02997A (de) 2012-11-05 2015-09-25 Procter & Gamble
US9827082B2 (en) 2013-02-26 2017-11-28 Orthoaccel Technologies, Inc. Fluoride releasing bite plate
WO2014169109A1 (en) 2013-04-10 2014-10-16 The Procter & Gamble Company Oral care compositions containing polyorganosilsesquioxane particles
US9192563B2 (en) 2013-04-10 2015-11-24 The Procter & Gamble Company Oral care compositions containing polyorganosilsesquioxane particles
WO2014169082A1 (en) 2013-04-10 2014-10-16 The Procter & Gamble Company Oral care compositions containing polyorganosilsesquioxane particles
US9572212B2 (en) 2014-05-21 2017-02-14 Lumens Co., Ltd. LED lighting device using AC power supply
US10927197B2 (en) 2015-08-04 2021-02-23 Isp Investments Llc Polymers derived from amino-functional vinyl alcohol ethers and applications thereof
CA3027948C (en) 2015-12-15 2023-01-24 John A. Gontarz Compositions comprising chlorine dioxide and dianhydrohexitol for the removal of tartar and plaque from teeth
CN111032004B (zh) 2017-12-20 2023-10-20 弗门尼舍有限公司 口腔护理组合物
CN111032003B (zh) 2017-12-21 2023-03-17 弗门尼舍有限公司 清凉和风味增强组合物
EP3958983A1 (de) 2019-04-26 2022-03-02 The Procter & Gamble Company Reduktion von zahnverfärbung aus kationischen antimikrobiellen mitteln
WO2021102896A1 (en) 2019-11-29 2021-06-03 Givaudan Sa Organic compounds
WO2021174475A1 (en) 2020-03-05 2021-09-10 Givaudan Sa Organic compounds
GB202012170D0 (en) 2020-08-05 2020-09-16 Givaudan Sa Organic compounds
WO2022170519A1 (en) 2021-02-09 2022-08-18 Givaudan Sa Organic compounds
GB202105661D0 (en) 2021-04-21 2021-06-02 Givaudan Sa Organic compounds

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608057A (en) * 1967-10-03 1971-09-21 Amicon Corp Process for making contact lenses
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US3867190A (en) * 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
US4048256A (en) * 1976-06-01 1977-09-13 American Cyanamid Company Normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product
US4328204A (en) * 1977-03-02 1982-05-04 Ethicon, Inc. Absorbable polymer-drug compounds and method for making same
US4293539A (en) * 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
US4454110A (en) * 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity
US4443430A (en) * 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
US4685883A (en) * 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
GR80494B (en) * 1983-10-07 1985-02-04 Forsyth Dental Infirmary Intra-pocket drug delivery devices for treatment of periodontal diseases
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4670252A (en) * 1985-05-24 1987-06-02 The Procter & Gamble Company Treatment of oral diseases
US4624256A (en) * 1985-09-11 1986-11-25 Pfizer Hospital Products Group, Inc. Caprolactone polymers for suture coating
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
JPH0617300B2 (ja) * 1986-09-22 1994-03-09 サンスタ−株式会社 歯周疾患治療用組成物
DE3708916A1 (de) * 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
JPH0645535B2 (ja) * 1987-05-20 1994-06-15 サンスタ−株式会社 歯槽骨代謝治療用組成物
IL86802A0 (en) * 1987-06-30 1988-11-30 Vipont Pharma Drug delivery devices
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5005074A (en) * 1989-11-17 1991-04-02 Rca Licensing Corporation Adaptive multistandard video comb filter

Also Published As

Publication number Publication date
KR910009243A (ko) 1991-06-28
FI98126B (fi) 1997-01-15
AU648278B2 (en) 1994-04-21
IE66371B1 (en) 1995-12-27
ES2067696T3 (es) 1995-04-01
DK0430474T3 (da) 1995-04-03
FI905683A (fi) 1991-05-18
EP0430474A1 (de) 1991-06-05
JPH03271219A (ja) 1991-12-03
CA2029046A1 (en) 1991-05-18
NZ236113A (en) 1993-05-26
AU6667690A (en) 1991-05-23
GR3015027T3 (en) 1995-05-31
JP3051154B2 (ja) 2000-06-12
KR0156917B1 (ko) 1998-11-16
CA2029046C (en) 1995-03-28
FI905683A0 (fi) 1990-11-16
FI98126C (fi) 1997-04-25
IE904147A1 (en) 1991-05-22
US5198220A (en) 1993-03-30
EP0430474B1 (de) 1995-02-08
DE69016755T2 (de) 1995-09-21
ATE118170T1 (de) 1995-02-15

Similar Documents

Publication Publication Date Title
DE69016755D1 (de) Pharmazeutische Zubereitung mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen.
ATE151282T1 (de) Zusammensetzungen mit verzögerter wirkstoffabgabe zur behandlung periodontaler erkrankungen
ATE133859T1 (de) Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen
DE3781928D1 (de) Arzneimittel mit verzoegerter freisetzung.
FI905682A (fi) Menetelmä hidastetusti vapauttavien koostumusten valmistamiseksi
DE68915132D1 (de) Verfahren zur Behandlung von Periodontitis durch protrahierte Wirkstoffabgabe von Arzneimitteln in der Zahnhöhle, Zusammensetzung davon und Vorrichtung zur Verabreichung.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee